Ali Akbar Fazaeli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ali Akbar Fazaeli has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah Mohammed Samy
Entomology Department, Faculty of Science, Ain Shams University, Cairo, Egypt
4 shared publications - Adnan Kisa
Department of Health and Exercise, Faculty of Health Sciences and Technology, Kristiania University of Applied Sciences, Norway
4 shared publications - Ali Bijani
Social Determinant of Health Research Center, Babol University of Medical Sciences, Babol, Iran
4 shared publications Ali H Mokdad
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
4 shared publicationsAlireza Rafiei
Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran
4 shared publicationsAmir Kasaeian
Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- 7 August 2026
- Published by Taylor & Francis in International Journal of Audiology
- p. 1-8
Cost-effectiveness of hearing screening in preschool children: a systematic review
Auditory function constitutes a fundamental prerequisite for the optimal development of language, speech, cognition, and social interactions in the paediatric population (Tissera et al. 2025). Whil...
- 7 August 2026
- Published by Taylor & Francis in International Journal of Audiology
- p. 1-8
Cost-effectiveness of hearing screening in preschool children: a systematic review
Auditory function constitutes a fundamental prerequisite for the optimal development of language, speech, cognition, and social interactions in the paediatric population (Tissera et al. 2025). Whil...
- Open Access
- 1 June 2026
- Published by InkVista Publishing House
- Vol. 25 (3) , 319-334
Analysis of push and pull factors in nurse migration: A scoping review
Objective(s): In recent decades, the migration of nurses has escalated significantly, reaching a critical juncture. This trend, primarily observed in the movement from developing to developed countries, presents a formidable challenge to enhancing health systems in the countries of origin. Understanding the underlying causes of nurse migration is a crucial first step toward ...
- 1 June 2026
- Published by InkVista Publishing House
- Vol. 25 (3) , 319-334
Open AccessAnalysis of push and pull factors in nurse migration: A scoping review
Objective(s): In recent decades, the migration of nurses has escalated significantly, reaching a critical juncture. This trend, primarily observed in the movement from developing to developed countries, presents a formidable challenge to enhancing health systems in the countries of origin. Understanding the underlying causes of nurse migration is a crucial first step toward ...
- Open Access
- 31 May 2026
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 59 (3) , 298-307
Contribution of Medication Expenditures to Catastrophic Health Expenditures in Iran: An Inequality Analysis
Objectives: Catastrophic health expenditures (CHE) is a well-established indicator of financial risk protection. This study aimed to examine the contribution of medication expenditure to CHE and the associated socioeconomic inequalities.Methods: Data were drawn from 6 nationally representative income and expenditure surveys covering the period 2019–2024. Using the budget share method, CHE was defined as out-of-pocket (OOP) health payments exceeding 25% of a household’s total consumption expenditure. The contribution of medication expenditures to CHE was then calculated as the difference in the proportion of households experiencing CHE with and without medication payments. Socioeconomic inequalities were quantified using the Concentration Index (CI), and decomposition analysis was conducted to identify the primary drivers of overall socioeconomic inequality in the contribution of medication expenditures to CHE.Results: During the study period, medications represented a substantial share of household health expenditures and contributed to CHE. In 2024, OOP spending on medications accounted for 31.2% of total health expenditures, while the contribution of medication expenditures to CHE was 1.28%. The CI indicated that the contribution of medication expenditures to CHE was concentrated among poorer households. Decomposition analysis further identified medium-sized households, male-headed households, households with employed heads, insured households, and urban households as the main contributors to this socioeconomic inequality.Conclusions: In Iran, OOP payments for medications constitute a substantial share of household healthcare expenditures and contribute to CHE. Because the roots of inequality extend beyond the healthcare system, addressing this issue requires a comprehensive, cross-sectoral strategy that integrates broader social and economic policies.
- 31 May 2026
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 59 (3) , 298-307
Open AccessContribution of Medication Expenditures to Catastrophic Health Expenditures in Iran: An Inequality Analysis
Objectives: Catastrophic health expenditures (CHE) is a well-established indicator of financial risk protection. This study aimed to examine the contribution of medication expenditure to CHE and the associated socioeconomic inequalities.Methods: Data were drawn from 6 nationally representative income and expenditure surveys covering the period 2019–2024. Using the budget share method, CHE was defined as out-of-pocket (OOP) health payments exceeding 25% of a household’s total consumption expenditure. The contribution of medication expenditures to CHE was then calculated as the difference in the proportion of households experiencing CHE with and without medication payments. Socioeconomic inequalities were quantified using the Concentration Index (CI), and decomposition analysis was conducted to identify the primary drivers of overall socioeconomic inequality in the contribution of medication expenditures to CHE.Results: During the study period, medications represented a substantial share of household health expenditures and contributed to CHE. In 2024, OOP spending on medications accounted for 31.2% of total health expenditures, while the contribution of medication expenditures to CHE was 1.28%. The CI indicated that the contribution of medication expenditures to CHE was concentrated among poorer households. Decomposition analysis further identified medium-sized households, male-headed households, households with employed heads, insured households, and urban households as the main contributors to this socioeconomic inequality.Conclusions: In Iran, OOP payments for medications constitute a substantial share of household healthcare expenditures and contribute to CHE. Because the roots of inequality extend beyond the healthcare system, addressing this issue requires a comprehensive, cross-sectoral strategy that integrates broader social and economic policies.
- Open Access
- 15 September 2025
- Published by Maad Rayan Publishing Company in Journal Of Research In Health Sciences
- Vol. 25 (4) , e00665
Economic Burden of Tuberculosis in Iran: A Nationwide Analysis by Drug Resistance and Cost Components
Background: Tuberculosis (TB) remains a significant global health crisis, regaining its status as the leading cause of death in 2023. Quantifying its economic burden is essential for crafting effective public health strategies. This study aimed to estimate the economic burden of TB in Iran. Study Design: This study employed a cross-sectional design. Methods: A prevalence-based approach was used to estimate the economic burden of TB in Iran, accounting for cost variations across TB types and cost categories. Costs were categorized as direct medical, direct non-medical, and indirect, and were calculated for suspected TB patients as well as for those with drug-sensitive TB, multidrug-resistant TB, and extensively drug-resistant TB. Data were extracted from various sources, including the National Tuberculosis Registration System, national TB diagnosis and treatment guidelines in Iran, official medical service tariffs, and previous studies. Results: Of 210,544 individuals screened, 7,221 were diagnosed with TB, of whom 81.0% had pulmonary TB and 19.0% had extrapulmonary TB. Drug-sensitive TB accounted for 99.4% of cases, multidrug-resistant TB 0.6%, and extensively drug-resistant TB 0.0%. Diagnostic costs represented 48.0% of the total economic burden (approximately Int’l$4.71 million), while post-diagnosis costs totaled Int’l$5.15 million. Overall, economic burden, including all diagnostic and treatment expenses, amounted to approximately Int’l$9.86 million. Conclusion: This study underscores the significant economic burden of TB in Iran, encompassing both pre-diagnosis and post-diagnosis expenses, with direct medical costs representing the largest component. Effective healthcare strategies and comprehensive public health approaches are crucial to reducing these costs and improving patient outcomes.
- 15 September 2025
- Published by Maad Rayan Publishing Company in Journal Of Research In Health Sciences
- Vol. 25 (4) , e00665
Open AccessEconomic Burden of Tuberculosis in Iran: A Nationwide Analysis by Drug Resistance and Cost Components
Background: Tuberculosis (TB) remains a significant global health crisis, regaining its status as the leading cause of death in 2023. Quantifying its economic burden is essential for crafting effective public health strategies. This study aimed to estimate the economic burden of TB in Iran. Study Design: This study employed a cross-sectional design. Methods: A prevalence-based approach was used to estimate the economic burden of TB in Iran, accounting for cost variations across TB types and cost categories. Costs were categorized as direct medical, direct non-medical, and indirect, and were calculated for suspected TB patients as well as for those with drug-sensitive TB, multidrug-resistant TB, and extensively drug-resistant TB. Data were extracted from various sources, including the National Tuberculosis Registration System, national TB diagnosis and treatment guidelines in Iran, official medical service tariffs, and previous studies. Results: Of 210,544 individuals screened, 7,221 were diagnosed with TB, of whom 81.0% had pulmonary TB and 19.0% had extrapulmonary TB. Drug-sensitive TB accounted for 99.4% of cases, multidrug-resistant TB 0.6%, and extensively drug-resistant TB 0.0%. Diagnostic costs represented 48.0% of the total economic burden (approximately Int’l$4.71 million), while post-diagnosis costs totaled Int’l$5.15 million. Overall, economic burden, including all diagnostic and treatment expenses, amounted to approximately Int’l$9.86 million. Conclusion: This study underscores the significant economic burden of TB in Iran, encompassing both pre-diagnosis and post-diagnosis expenses, with direct medical costs representing the largest component. Effective healthcare strategies and comprehensive public health approaches are crucial to reducing these costs and improving patient outcomes.
- 29 April 2025
- Published by Elsevier in Health Policy and Technology
- Vol. 14 (3)
Volume-cost relationship in Pancreatic Surgery: A scoping review
- 29 April 2025
- Published by Elsevier in Health Policy and Technology
- Vol. 14 (3)
Volume-cost relationship in Pancreatic Surgery: A scoping review
- Open Access
- 1 February 2025
- Published by Apex Publishing in Payesh (Health Monitor) Journal
- Vol. 24 (1) , 7-19
Analysis of national health accounts in Iran (2002–2020)
Objective (s): Comprehensive data on health expenditures is crucial not only for effective policymaking but also for achieving universal health coverage and health-related sustainable development goals. This study provides a detailed analysis of Iran's national health accounts from 2002 to 2020, offering insights into trends and patterns in healthcare spending during ...
- 1 February 2025
- Published by Apex Publishing in Payesh (Health Monitor) Journal
- Vol. 24 (1) , 7-19
Open AccessAnalysis of national health accounts in Iran (2002–2020)
Objective (s): Comprehensive data on health expenditures is crucial not only for effective policymaking but also for achieving universal health coverage and health-related sustainable development goals. This study provides a detailed analysis of Iran's national health accounts from 2002 to 2020, offering insights into trends and patterns in healthcare spending during ...
- Open Access
- 1 November 2024
- Published by Apex Publishing in Journal of Health Administration
- Vol. 27 (2) , 90-108
Nurse migration management strategies: a scoping review
Introduction: The migration of nurses leads to a shortage of human resources in healthcare systems, a decrease in the quality of health services, an increased workload on the remaining staff, and reduced access to effective healthcare services for vulnerable populations. This study aimed to identify strategies for managing nurse migration. Methods: In ...
- 1 November 2024
- Published by Apex Publishing in Journal of Health Administration
- Vol. 27 (2) , 90-108
Open AccessNurse migration management strategies: a scoping review
Introduction: The migration of nurses leads to a shortage of human resources in healthcare systems, a decrease in the quality of health services, an increased workload on the remaining staff, and reduced access to effective healthcare services for vulnerable populations. This study aimed to identify strategies for managing nurse migration. Methods: In ...
- Open Access
- 26 February 2024
- Published by Springer Nature in BMC Health Services Research
- Vol. 24 (1) , 1-16
Exploring the driving forces and scenario analysis for catastrophic and impoverishing health expenditures in Iran
Background: The extent of healthcare expenditure within households stands as a crucial indicator in low and middle-income countries (LMICs). When out-of-pocket healthcare expenses surpass household income or become unduly burdensome, it serves as a significant socio-economic alarm, resulting in a reduced quality of life, a phenomenon referred to as ‘catastrophic health expenditure (CHE).’ Multiple factors can contribute to the occurrence of CHE. The study’s objective was to identify the key uncertainties and driving forces influencing CHE to develop scenarios in Iran on the horizon of 2030. Methods: This study was conducted between December 2021 and January 2023, data were collected through a literature review, and experts’ opinions were gathered via questionnaires, interviews, and expert panels. The statistical population included experts in the fields of health policy, health economics, and futures studies. Scenario Wizard software and MICMAC analysis were employed for data analysis, providing valuable insights into potential future scenarios of health expenditures in Iran. Results: Based on the results of the scoping review and semi-structured interview, 65 key factors in the fields of economics, politics, technology, social, and environmental were identified. The findings of the MICMAC analysis presented 10 key variables. Finally, six main scenario spaces are depicted using Scenario Wizard. These scenarios included catastrophic cost crises, sanction relief, selective information access, technological ambiguity, induced demand management, and incremental reforms. Conclusions: Each of the six drawn scenarios provides images of the future of health expenditure in Iranian households on the horizon of 2030. The worst-case scenario from all scenarios was scenario one, with the most probable and critical features to derive Iran’s health expenditures. The current study is a valuable addition to the literature depicting the key drivers that all developing nations can consider to decrease exposing households to catastrophic and impoverishing health expenditures.
- 26 February 2024
- Published by Springer Nature in BMC Health Services Research
- Vol. 24 (1) , 1-16
Open AccessExploring the driving forces and scenario analysis for catastrophic and impoverishing health expenditures in Iran
Background: The extent of healthcare expenditure within households stands as a crucial indicator in low and middle-income countries (LMICs). When out-of-pocket healthcare expenses surpass household income or become unduly burdensome, it serves as a significant socio-economic alarm, resulting in a reduced quality of life, a phenomenon referred to as ‘catastrophic health expenditure (CHE).’ Multiple factors can contribute to the occurrence of CHE. The study’s objective was to identify the key uncertainties and driving forces influencing CHE to develop scenarios in Iran on the horizon of 2030. Methods: This study was conducted between December 2021 and January 2023, data were collected through a literature review, and experts’ opinions were gathered via questionnaires, interviews, and expert panels. The statistical population included experts in the fields of health policy, health economics, and futures studies. Scenario Wizard software and MICMAC analysis were employed for data analysis, providing valuable insights into potential future scenarios of health expenditures in Iran. Results: Based on the results of the scoping review and semi-structured interview, 65 key factors in the fields of economics, politics, technology, social, and environmental were identified. The findings of the MICMAC analysis presented 10 key variables. Finally, six main scenario spaces are depicted using Scenario Wizard. These scenarios included catastrophic cost crises, sanction relief, selective information access, technological ambiguity, induced demand management, and incremental reforms. Conclusions: Each of the six drawn scenarios provides images of the future of health expenditure in Iranian households on the horizon of 2030. The worst-case scenario from all scenarios was scenario one, with the most probable and critical features to derive Iran’s health expenditures. The current study is a valuable addition to the literature depicting the key drivers that all developing nations can consider to decrease exposing households to catastrophic and impoverishing health expenditures.
- Open Access
- 5 February 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-13
Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019–2022
During a COVID-19 pandemic, it is imperative to investigate the outcomes of all non-COVID-19 diseases. This study determines hospital admissions and mortality rates related to non-COVID-19 diseases during the COVID-19 pandemic among 41 million Iranians. This nationwide retrospective study used data from the Iran Health Insurance Organization. From September 23, 2019, to Feb 19, 2022, there were four study periods: pre-pandemic (Sept 23-Feb 19, 2020), first peak (Mar 20-Apr 19, 2020), first year (Feb 20, 2020-Feb 18, 2021), and the second year (Feb 19, 2021-Feb 19, 2022) following the pandemic. Cause-specific hospital admission and in-hospital mortality are the main outcomes analyzed based on age and sex. Negative binomial regression was used to estimate the monthly adjusted Incidence Rate Ratio (IRR) to compare hospital admission rates in aggregated data. A logistic regression was used to estimate the monthly adjusted in-hospital mortality Odds Ratio (OR) for different pandemic periods. During the study there were 6,522,114 non-COVID-19 hospital admissions and 139,679 deaths. Prior to the COVID-19 outbreak, the standardized hospital admission rate per million person-month was 7115.19, which decreased to 2856.35 during the first peak (IRR 0.40, [0.25–0.64]). In-hospital mortality also increased from 20.20 to 31.99 (OR 2.05, [1.97–2.13]). All age and sex groups had decreased admission rates, except for females at productive ages. Two years after the COVID-19 outbreak, the non-COVID-19 hospital admission rate (IRR 1.25, [1.13–1.40]) and mortality rate (OR 1.05, [1.04–1.07]) increased compared to the rates before the pandemic. The respiratory disease admission rate decreased in the first (IRR 0.23, [0.17–0.31]) and second years (IRR 0.35, [0.26–0.47] compared to the rate before the pandemic. There was a significant reduction in hospitalizations for pneumonia (IRR 0.30, [0.21–0.42]), influenza (IRR 0.04, [0.03–0.06]) and COPD (IRR 0.39, [0.23–0.65]) during the second year. There was a significant and continuous rise in the hematological admission rate during the study, reaching 186.99 per million person-month in the second year, reflecting an IRR of 2.84 [2.42–3.33] compared to the pre-pandemic period. The mortality rates of mental disorders (OR 2.15, [1.65–2.78]) and musculoskeletal (OR 1.48, [1.20–1.82), nervous system (OR 1.42, [1.26–1.60]), metabolic (OR 1.99, [1.80–2.19]) and circulatory diseases (OR 1.35, [1.31–1.39]) increased in the second year compare to pre-pandemic. Myocardial infarction (OR 1.33, [1.19–1.49]), heart failure (OR 1.59, [1.35–1.87]) and stroke (OR 1.35, [1.24–1.47]) showed an increase in mortality rates without changes in hospitalization. In the era of COVID-19, the changes seem to have had a long-term effect on non-COVID-19 diseases. Countries should prepare for similar crises in the future to ensure medical services are not suspended.
- 5 February 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-13
Open AccessNon-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019–2022
During a COVID-19 pandemic, it is imperative to investigate the outcomes of all non-COVID-19 diseases. This study determines hospital admissions and mortality rates related to non-COVID-19 diseases during the COVID-19 pandemic among 41 million Iranians. This nationwide retrospective study used data from the Iran Health Insurance Organization. From September 23, 2019, to Feb 19, 2022, there were four study periods: pre-pandemic (Sept 23-Feb 19, 2020), first peak (Mar 20-Apr 19, 2020), first year (Feb 20, 2020-Feb 18, 2021), and the second year (Feb 19, 2021-Feb 19, 2022) following the pandemic. Cause-specific hospital admission and in-hospital mortality are the main outcomes analyzed based on age and sex. Negative binomial regression was used to estimate the monthly adjusted Incidence Rate Ratio (IRR) to compare hospital admission rates in aggregated data. A logistic regression was used to estimate the monthly adjusted in-hospital mortality Odds Ratio (OR) for different pandemic periods. During the study there were 6,522,114 non-COVID-19 hospital admissions and 139,679 deaths. Prior to the COVID-19 outbreak, the standardized hospital admission rate per million person-month was 7115.19, which decreased to 2856.35 during the first peak (IRR 0.40, [0.25–0.64]). In-hospital mortality also increased from 20.20 to 31.99 (OR 2.05, [1.97–2.13]). All age and sex groups had decreased admission rates, except for females at productive ages. Two years after the COVID-19 outbreak, the non-COVID-19 hospital admission rate (IRR 1.25, [1.13–1.40]) and mortality rate (OR 1.05, [1.04–1.07]) increased compared to the rates before the pandemic. The respiratory disease admission rate decreased in the first (IRR 0.23, [0.17–0.31]) and second years (IRR 0.35, [0.26–0.47] compared to the rate before the pandemic. There was a significant reduction in hospitalizations for pneumonia (IRR 0.30, [0.21–0.42]), influenza (IRR 0.04, [0.03–0.06]) and COPD (IRR 0.39, [0.23–0.65]) during the second year. There was a significant and continuous rise in the hematological admission rate during the study, reaching 186.99 per million person-month in the second year, reflecting an IRR of 2.84 [2.42–3.33] compared to the pre-pandemic period. The mortality rates of mental disorders (OR 2.15, [1.65–2.78]) and musculoskeletal (OR 1.48, [1.20–1.82), nervous system (OR 1.42, [1.26–1.60]), metabolic (OR 1.99, [1.80–2.19]) and circulatory diseases (OR 1.35, [1.31–1.39]) increased in the second year compare to pre-pandemic. Myocardial infarction (OR 1.33, [1.19–1.49]), heart failure (OR 1.59, [1.35–1.87]) and stroke (OR 1.35, [1.24–1.47]) showed an increase in mortality rates without changes in hospitalization. In the era of COVID-19, the changes seem to have had a long-term effect on non-COVID-19 diseases. Countries should prepare for similar crises in the future to ensure medical services are not suspended.
- Open Access
- 31 January 2024
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 57 (1) , 65-72
Prevalence and Determinants of Catastrophic Healthcare Expenditures in Iran From 2013 to 2019
Objectives: Protecting people against financial hardship caused by illness stands as a fundamental obligation within healthcare systems and constitutes a pivotal component in achieving universal health coverage. The objective of this study was to analyze the prevalence and determinants of catastrophic health expenditures (CHE) in Iran, over the period of 2013 to 2019.Methods: Data were obtained from 7 annual national surveys conducted between 2013 and 2019 on the income and expenditures of Iranian households. The prevalence of CHE was determined using a threshold of 40% of household capacity to pay for healthcare. A binary logistic regression model was used to identify the determinants influencing CHE.Results: The prevalence of CHE increased from 3.60% in 2013 to 3.95% in 2019. In all the years analyzed, the extent of CHE occurrence among rural populations exceeded that of urban populations. Living in an urban area, having a higher wealth index, possessing health insurance coverage, and having employed family members, an employed household head, and a literate household head are all associated with a reduced likelihood of CHE (p<0.05). Conversely, the use of dental, outpatient, and inpatient care, and the presence of elderly members in the household, are associated with an increased probability of facing CHE (p<0.05).Conclusions: Throughout the study period, CHE consistently exceeded the 1% threshold designated in the national development plan. Continuous monitoring of CHE and its determinants at both household and health system levels is essential for the implementation of effective strategies aimed at enhancing financial protection.
- 31 January 2024
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 57 (1) , 65-72
Open AccessPrevalence and Determinants of Catastrophic Healthcare Expenditures in Iran From 2013 to 2019
Objectives: Protecting people against financial hardship caused by illness stands as a fundamental obligation within healthcare systems and constitutes a pivotal component in achieving universal health coverage. The objective of this study was to analyze the prevalence and determinants of catastrophic health expenditures (CHE) in Iran, over the period of 2013 to 2019.Methods: Data were obtained from 7 annual national surveys conducted between 2013 and 2019 on the income and expenditures of Iranian households. The prevalence of CHE was determined using a threshold of 40% of household capacity to pay for healthcare. A binary logistic regression model was used to identify the determinants influencing CHE.Results: The prevalence of CHE increased from 3.60% in 2013 to 3.95% in 2019. In all the years analyzed, the extent of CHE occurrence among rural populations exceeded that of urban populations. Living in an urban area, having a higher wealth index, possessing health insurance coverage, and having employed family members, an employed household head, and a literate household head are all associated with a reduced likelihood of CHE (p<0.05). Conversely, the use of dental, outpatient, and inpatient care, and the presence of elderly members in the household, are associated with an increased probability of facing CHE (p<0.05).Conclusions: Throughout the study period, CHE consistently exceeded the 1% threshold designated in the national development plan. Continuous monitoring of CHE and its determinants at both household and health system levels is essential for the implementation of effective strategies aimed at enhancing financial protection.